Kanserde Unutulmuş Tedaviler

Popescu RA, Schäfer R, Califano R, et al. The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO). Annals of oncology. 2014;25(1):9-15.

Macklis RM. The History of Oncology. International Journal of Radiation Oncology, Biology, Physics. 2009;75(5):1622.

Reedy, Jeremiah. "Galen on cancer and related diseases." 1975: 227-238.

Dunker MF. A history of early antiseptics. Journal of chemical education. 1938;15(2):58.

Robinson DH, Toledo AH. Historical development of modern anesthesia. J Invest Surg. 2012;25(3):141-9.

Faguet GB. A brief history of cancer: age‐old milestones underlying our current knowledge database. International journal of cancer. 2015;136(9):2022-36.

DeVita Jr VT, Chu E. A history of cancer chemotherapy. Cancer research. 2008;68(21):8643-53.

Maloney KW, Devidas M, Mattano Jr LA, et al. Excellent event free (EFS) and overall survival (OS) for children with standard risk acute lymphoblastic leukemia (SR ALL) despite the absence of a significant impact on outcome with the addition of an intensified consolidation: Results of Children's Oncology Group (COG) AALL0331. Blood. 2013;122(21):837.

TP M. CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin's lymphomas: Update of the Southwest Oncology Group (SWOG) randomized trial. Blood. 2001;98:724a-5a.

Yamaguchi K, Fujisawa M. Anticancer chemotherapeutic agents and testicular dysfunction. Reprod Med Biol. 2011;10(2):81-87.

El Saghir NS, Khalil LE, El Dick J, et al. Improved survival of young patients with breast cancer 40 years and younger at diagnosis. JCO Global Oncology. 2023;9:e2200354.

Do Huh H, Kim S. History of radiation therapy technology. Progress in Medical Physic. 2020;31(3):124-34.

Biersack HJ, Briele B, Hotze AL, Oehr P, Qian L, Mekkawy MA, Shih WJ. The role of nuclear medicine in oncology. Ann Nucl Med. 1992;6(3):131-6.

Zhou Z, Li M. Targeted therapies for cancer. BMC medicine. 2022;20(1):90.

Assal A, Kaner J, Pendurti G, Zang X. Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1. Immunotherapy. 2015;7(11):1169-86.

Majumder A. Evolving CAR-T-Cell Therapy for Cancer Treatment: From Scientific Discovery to Cures. Cancers. 2023;16(1):39.

Pappalardo F, Chiacchio F, Motta S. Cancer vaccines: state of the art of the computational modeling approaches. BioMed research international. 2013.

Selin S. Cancer Treatment in the 19th Century, 2017. https://shannonselin.com/2017/08/cancer-treatment-19th-century/

Jiang T, Zhou C, Ren S. Role of IL-2 in cancer immunotherapy. Oncoimmunology. 2016 Apr 25;5(6):e1163462.

Eleutherakis-Papaiakovou V, Bamias A, Dimopoulos MA. Thalidomide in cancer medicine. Annals of Oncology. 2004;15(8):1151-60.

Corrêa FD, Guerra RL, Fernandes RR, Souza MC, Zimmermann IR. Target therapy versus dacarbazine in first-line treatment of advanced non-surgical and metastatic melanoma: budget impact analysis from the perspective of the Brazilian National Health System, 2018-2020. Epidemiologia e Serviços de Saúde. 2019;28:e2018325.

Bradner WT. Mitomycin C: a clinical update. Cancer treatment reviews. 2001;27(1):35-50.

Armand JP, Ribrag V, Harrousseau JL, Abrey L. Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors. Therapeutics and clinical risk management. 2007;3(2):213-24.

Cao GD, He XB, Sun Q, Chen S, Wan K, Xu X, Feng X, Li PP, Chen B, Xiong MM. The oncolytic virus in cancer diagnosis and treatment. Frontiers in Oncology. 2020;10:1786.

Siebert A, Deptuła M, Cichorek M, Ronowska A, Cholewiński G, Rachon J. Anticancer properties of amino acid and peptide derivatives of mycophenolic acid. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2021;21(4):462-7.

Zhao M, Li Y, Wang Z. Mercury and Mercury-Containing Preparations: History of Use, Clinical Applications, Pharmacology, Toxicology, and Pharmacokinetics in Traditional Chinese Medicine. Front Pharmacol. 2022;13:807807.

Wellcome Fotograf https://wellcomeimages.org/

Plesca M, Bordea C, El Houcheimi B, Ichim E, Blidaru A. Evolution of radical mastectomy for breast cancer. Journal of medicine and life. 2016;9(2):183.

Kuerer HM: Kuerer'in Meme kanseri cerrahi onkolojisi: http://www.accessurgery.com

Martini N, Bains MS, Beattie Jr EJ. Indications for pleurectomy in malignant effusion. Cancer. 1975;35(3):734-8.

Yan S, Gritsiuta AI, del Rosal GM, Jones G, Rocco G, Jones DR. Pneumonectomy for lung cancer. Shanghai Chest. 2020;4.

Rerkasem A, Orrapin S, Howard DP, Rerkasem K. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev. 2020;9(9):CD001081.

Das G, Sahewalla A, Purkayastha J, Talukdar A, Kalita D, Kamalasanan K, Kakoti L. Pelvic Exenteration for Locally Advanced Rectal Cancer: an Initial Experience from North-east India. Indian J Surg Oncol. 2022;13(3):559-563.

Elkolaly RM, Korraa EE, Ibrahim IS. Electrocautery and cryotherapy in inoperable malignant lung lesions. Egyptian Journal of Bronchology. 2017;11:74-80.

Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29-42.

Schröder S, Lee S, Efferth T, Motoo Y. Acupuncture and herbal medicine for cancer patients. Evidence-Based Complementary and Alternative Medicine. 2013.

Kaynak: Wellcome Library, Londra

Bayle GL, Cayole JB. Dictionnaire des sciences médicales. Paris, Panckoucke, 1812.

Benett AH. On cancerous and cancroids growths. Edinburgh, Sutherland and Knox, 1849.

Zdrojewicz Z, Strzelczyk J. Radon treatment controversy. Dose-Response. 2006;4(2):dose-response.

Tapley ND. The electron beam in tumor therapy. Hospital Practice. 1968;3(6):48-51.

Androutsos G, Koutsilieris M, Protogerou A, Laios K, Karamanou M. Popular palliative cancer treatments in 18th–mid 19th century. J BUON. 2016;21:523-7.

Palmer JF (Ed). The works of John Hunter, F.R.S. with notes. London, Logman, 1835.

Broka P. Traité des tumeurs, Vol.1. Paris, Asselin, 1866.